[2-(3H-Indol-3-yl)-ethyl]-(9H-purin-6-yl)-amine

ID: ALA362958

PubChem CID: 44400278

Max Phase: Preclinical

Molecular Formula: C15H14N6

Molecular Weight: 278.32

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C1=Nc2ccccc2C1CCNc1[nH]cnc2ncnc1-2

Standard InChI:  InChI=1S/C15H14N6/c1-2-4-12-11(3-1)10(7-17-12)5-6-16-14-13-15(19-8-18-13)21-9-20-14/h1-4,7-10H,5-6H2,(H2,16,18,19,20,21)

Standard InChI Key:  JUEVJILVDUGDAL-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 21 24  0  0  0  0  0  0  0  0999 V2000
    4.2375    0.3958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6875   -2.7667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2375    1.2208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4542    0.1375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4542    1.4708    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9500   -0.0167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9500    1.6333    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9667    0.8083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6542    0.3875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.1375   -2.1542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2750   -3.4792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4667   -3.3125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6667    1.2208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3792   -2.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9500   -0.8417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6667   -1.2542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9167   -3.9167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6667   -2.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5292   -4.2667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1667   -4.7042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9792   -4.8750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2 10  2  0
  3  1  1  0
  4  1  1  0
  5  3  2  0
  6  1  2  0
  7  3  1  0
  8  4  2  0
  9  6  1  0
 10 14  1  0
 11 12  2  0
 12 14  1  0
 13  9  1  0
 14 18  1  0
 15  6  1  0
 16 15  1  0
 17 12  1  0
 18 16  1  0
 19 11  1  0
 20 17  2  0
 21 20  1  0
  8  5  1  0
 13  7  2  0
  2 11  1  0
 19 21  2  0
M  END

Alternative Forms

Associated Targets(Human)

EPHB2 Tchem Ephrin type-B receptor 2 (1899 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 278.32Molecular Weight (Monoisotopic): 278.1280AlogP: 2.61#Rotatable Bonds: 4
Polar Surface Area: 78.85Molecular Species: ACIDHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 6.14CX Basic pKa: 4.74CX LogP: 1.09CX LogD: 0.46
Aromatic Rings: 1Heavy Atoms: 21QED Weighted: 0.77Np Likeness Score: -0.26

References

1. Toledo-Sherman L, Deretey E, Slon-Usakiewicz JJ, Ng W, Dai JR, Foster JE, Redden PR, Uger MD, Liao LC, Pasternak A, Reid N..  (2005)  Frontal affinity chromatography with MS detection of EphB2 tyrosine kinase receptor. 2. Identification of small-molecule inhibitors via coupling with virtual screening.,  48  (9): [PMID:15857128] [10.1021/jm0492204]

Source